Ventilator-associated pneumonia: Difference between revisions
Jump to navigation
Jump to search
m Robot: Automated text replacement (-msbeih@perfuse.org +msbeih@wikidoc.org, -psingh@perfuse.org +psingh13579@gmail.com, -agovi@perfuse.org +agovi@wikidoc.org, -rgudetti@perfuse.org +ravitheja.g@gmail.com, -lbiller@perfuse.org +lbiller@wikidoc.org,... |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Ventilator-associated pneumonia}} | {{Ventilator-associated pneumonia}} | ||
{{CMG}}; '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.D.]] [mailto:psingh13579@gmail.com] | {{CMG}}; '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.D.]] [mailto:psingh13579@gmail.com] | ||
| Line 5: | Line 6: | ||
==[[Ventilator-associated pneumonia pathophysiology|Pathophysiology]]== | ==[[Ventilator-associated pneumonia pathophysiology|Pathophysiology]]== | ||
==[[Ventilator-associated pneumonia causes|Causes]]== | ==[[Ventilator-associated pneumonia causes|Causes]]== | ||
==[[Pneumonia differential diagnosis| | ==[[Pneumonia differential diagnosis|Differentiating Ventilator-Associated Pneumonia from other Disease]]== | ||
==[[Pneumonia epidemiology and demographics|Epidemiology and Demographics]]== | ==[[Pneumonia epidemiology and demographics|Epidemiology and Demographics]]== | ||
==[[Ventilator-associated pneumonia risk factors|Risk Factors]]== | ==[[Ventilator-associated pneumonia risk factors|Risk Factors]]== | ||
| Line 16: | Line 16: | ||
==Treatment== | ==Treatment== | ||
[[Ventilator-associated pneumonia clinical strategy|Recommendations for clinical strategy]] | [[Ventilator-associated pneumonia medical therapy|Medical Therapy]] | [[Ventilator-associated pneumonia prevention|Prevention]] | [[Hospital-acquired pneumonia response to therapy|Assessing response to therapy]] | [[Ventilator-associated pneumonia clinical strategy|Recommendations for clinical strategy]] | [[Ventilator-associated pneumonia medical therapy|Medical Therapy]] | [[Ventilator-associated pneumonia prevention|Prevention]] | [[Hospital-acquired pneumonia response to therapy|Assessing response to therapy]] | ||
==Related Chapters== | |||
* [[Pneumonia]] | |||
* [[Nosocomial infection]] | |||
[[Category:Diseaase]] | [[Category:Diseaase]] | ||
[[Category:Pulmonology]] | [[Category:Pulmonology]] | ||
| Line 22: | Line 26: | ||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WS}} | {{WS}} | ||
Revision as of 21:26, 29 January 2013
Template:Ventilator-associated pneumonia Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.D. [2]
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Ventilator-Associated Pneumonia from other Disease
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic criteria | History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray
Treatment
Recommendations for clinical strategy | Medical Therapy | Prevention | Assessing response to therapy